Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Washer 

WAVE Life Sciences Ltd diskutieren

WAVE Life Sciences Ltd

WKN: A1436W / Symbol: WVE / Name: WAVE Life / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

?
-7,28 %

WAVE Life Sciences (NASDAQ:WVE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 146,40 %
Kursziel 13,85
Veränderung
Endet am 11.11.26

WAVE Life Sciences (NASDAQ:WVE) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $16.00. They now have an "overweight" rating on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 146,40 %
Kursziel 17,31
Veränderung
Endet am 11.11.26

WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Wedbush from $18.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for WVE provided by MarketBeat

WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,98 %
Kursziel 29,19
Veränderung
Endet am 09.12.26

WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $12.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for WVE provided by MarketBeat